1. Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline;Chang;J Urol,2017
2. European Association of Urology Guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines [internet];Witjes;Eur Urol,2021
3. Flaig, T. W., Spiess, P. E., Chair, V., Agarwal, N., Bangs, R., Boorjian, S. A., Buyyounouski, M. K., Chan, K., Chang, S., Downs, T. M., Friedlander, T., Helen Diller Family, U., Greenberg, R. E., Guru, K. A., Guzzo, T., ϖ, M., Herr, H. W., Hoffman-Censits, J., Inman, B. A., Dwyer, M. (2021). NCCN Guidelines Version 3.2021 Bladder Cancer. https://www.nccn.org/professionals/physician_gls/pdf/bladder.pdf. Accessed: May 26, 2021.
4. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline [internet];Chang;J Urol,2016
5. European Association of Urology Guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ)—2019 update [internet];Babjuk;Eur Urol,2019